Ondansetron induced torsades de pointes

Ondansetron induced torsades de pointes

Abstract A single dose of oral Ondansetron can precipitate torsades de pointes and other arrhythmias in patients with risk factors that may prolong QTc interval.

Bibliographic Details
Main Authors:	Eshan Patel, Danielle Rosemond, Ashwad Afzal
Format:	Article
Language:	English
Published:	Wiley 2019-08-01
Series:	Clinical Case Reports
Subjects:	antiemetic drug‐induced torsades Ondansetron QT prolongation torsades de pointes
Online Access:	https://doi.org/10.1002/ccr3.2251

Similar Items

Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes
by: Karthik Gnanapandithan, et al.
Published: (2021-02-01)

A case of hypoglycemiainduced QT prolongation leading to torsade de pointes and a review of pathophysiological mechanisms
by: Faris Hannoodi, et al.
Published: (2017-06-01)

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
by: Irina Nordkin, et al.
Published: (2021-01-01)

Methadone induced torsades de pointes and ventricular fibrillation: A case review
by: Somayeh Khalesi, et al.
Published: (2014-11-01)

Dofetilide induced torsade de pointes: Mechanism, risk factors and management strategies
by: Abhishek Jaiswal, et al.
Published: (2014-11-01)

Acquired long QT syndrome and Torsades de Poin
by: Ahmet Seyfeddin Gurbuz, et al.
Published: (2016-09-01)

Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation
by: Yae Min Park, et al.
Published: (2017-09-01)

A Case of Ciprofloxacin-Induced QT Prolongation and Torsade de Pointes
by: Hedieh Keshavarz-Bahaghighat, et al.
Published: (2017-09-01)

Multi-Factorial Causes of Torsade De Pointes in a Hospitalised Surgical Patient
by: Prashanth Panduranga, et al.
Published: (2013-02-01)

Recurrent takotsubo with prolonged QT and torsade de pointes and left ventricular thrombus
by: Alaa Eldin K. Ahmed, et al.
Published: (2017-01-01)

Prevention of Torsade de Pointes during the Pharmacologic Treatment of Atrial Fibrillation
by: Hideo Mitamura, MD, PhD
Published: (2010-01-01)

A hosszú-QT-szindróma és a torsades de pointes kamrai tachycardia története Historical overview of long-QT syndrome and torsades de pointes ventricular tachycardia
by: Fazekas Tamás, Prof. Dr
Published: (2012-12-01)

Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study
by: Qasim Khan, et al.
Published: (2017-12-01)

Nearly Fatal Torsade de Pointes with Sotalol
by: Bernhard Strohmer, et al.
Published: (2003-10-01)

In vivo analysis of torsadogenic potential of an antipsychotic drug paliperidone using the acute atrioventricular block rabbit as a proarrhythmia model
by: Mihoko Hagiwara, et al.
Published: (2016-09-01)

QT prolongation and torsades de pointes during emergency treatment with nifekalant for refractory ventricular tachyarrhythmias: Post-hoc analysis from a large-scale multicenter post-marketing survey in Japan
by: Takao Katoh, MD, et al.
Published: (2013-10-01)

Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose
by: Jan Albert Nicolaas Groot, et al.
Published: (2018-09-01)

Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
by: Biswadeep Das, et al.
Published: (2020-01-01)

Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia
by: Ryota Kitajima, MD, et al.
Published: (2017-10-01)

Effects of Cardiac Resynchronization Therapy on the Arrhythmic Substrate in a Patient with Long QT and Torsades de pointes
by: Masayasu Ikutomi, MD, et al.
Published: (2011-01-01)

Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model
by: Satoshi Kawakami, et al.
Published: (2020-11-01)

Torsade de pointes in liver transplantation recipient after induction of general anesthesia: a case report
by: Eun-Jin Chung, et al.
Published: (2014-01-01)

Long QT syndrome and torsades de pointes complicating mitral valve replacement
by: Shegu Gilbert, et al.
Published: (2016-09-01)

Risperidone alone did not induce torsade de pointes: Experimental evidence from the chronic atrioventricular block model dogs
by: Yoshio Nunoi, et al.
Published: (2020-08-01)

Incidence of drug-induced torsades de pointes with intravenous amiodarone
by: Jayaprakash Shenthar, et al.
Published: (2017-11-01)

Intravenous anti-influenza drug oseltamivir will not induce torsade de pointes: Evidences from proarrhythmia model and action-potential assay
by: Yuji Nakamura, et al.
Published: (2016-05-01)

Postanesthetic torsade de pointes in a patient with unrecognized long QT syndrome -A case report-
by: Jae-Young Lee, et al.
Published: (2011-04-01)

Identification of Patients At-Risk of QT Interval Prolongation during Medication Reviews: A Missed Opportunity?
by: Vera H. Buss, et al.
Published: (2018-12-01)

‘ Loperamide overdose induces ventricular tachycardia with catastrophic outcomes’
by: Zain Ali, et al.
Published: (2020-05-01)

Síndrome do QT longo e torsades de pointes pós-parto Síndrome de QT largo y torsades de pointes postparto Postpartum torsades de pointes and long QT syndrome
by: Alexandre Maulaz Barcelos, et al.
Published: (2009-10-01)

Uni- or Bi- Ventricular Hypertrophy and Susceptibility to Drug- induced Torsades de Pointes
by: Panyasing, Yaowalak
Published: (2010)

Patient safety: prescription of drugs that prolong the QT interval
by: María Jesús Hernández-Arroyo, et al.
Published: (2015-09-01)

Torsades de Pointes
by: Richard J Chen, MD, et al.
Published: (2018-04-01)

Suppression of cardiac memory–related severe form of torsades de pointes by landiolol in a patient with congenital long QT syndrome type 2
by: Sou Otsuki, MD, PhD, et al.
Published: (2020-07-01)

Long QT syndrome: A therapeutic challenge
by: Shah Maully, et al.
Published: (2008-01-01)

QT Prolongation in Cancer Patients
by: Peter Kim, et al.
Published: (2021-02-01)

Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study
by: Zahid Ali, et al.
Published: (2020-06-01)

A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation
by: Anand Prakash Singh, et al.
Published: (2020-06-01)

Dose-Dependent Effects of Methadone on QT interval in Patients under Methadone Maintenance Treatment
by: Farzad Gheshlaghi, et al.
Published: (2013-03-01)

Drug-Induced Long-QT and Torsades de Pointes in Elderly Polymedicated Patients
by: Daniel García-Fuertes, et al.
Published: (2016-02-01)

Cannot write session to /tmp/vufind_sessions/sess_lv28jq4o62r4ta5q9b80b82vod